Literature DB >> 9852257

Molecular dissection of B cell antigen receptor signaling (review).

T Kurosaki1.   

Abstract

In B lymphocytes, signaling through the B cell antigen receptor (BCR) contributes to cell fate decisions with different extents of receptor engagement leading to such outcomes as cell death, survival, or proliferation. During the past several years we have seen significant strides in our understanding of the signaling pathways that connect the BCR to the nucleus. Stimulation of the BCR leads to the activation of three types of intracellular protein tyrosine kinases Lyn, Syk, and Btk. Concerted action of these tyrosine kinases leads to the phosphorylation of multiple substrates and to activation of a variety of signaling pathways including phospholipase C-gamma, Ras, and phosphatidylinositol 3-kinase activation. The ability of B lymphocytes to react appropriately to a wide variety of environment stimuli requires a high degree of regulation on these multiple signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9852257     DOI: 10.3892/ijmm.1.3.515

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  8 in total

1.  Chronic lymphocytic leukemia B cells contain anomalous Lyn tyrosine kinase, a putative contribution to defective apoptosis.

Authors:  Antonella Contri; Anna Maria Brunati; Livio Trentin; Anna Cabrelle; Marta Miorin; Luca Cesaro; Lorenzo A Pinna; Renato Zambello; Gianpietro Semenzato; Arianna Donella-Deana
Journal:  J Clin Invest       Date:  2005-02       Impact factor: 14.808

2.  The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo.

Authors:  M Merchant; R G Caldwell; R Longnecker
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

Review 3.  Ibrutinib: from bench side to clinical implications.

Authors:  Davide Grisafi; Alessandra Maestro; Camilla Grumi; Ludovica Piazzoni; Giampaolo Tirone; Walter Fiore; Roberto Tessari; Valeria Gianardi; Milo Gatti; Francesca Tasca; Daniele Generali; Andrea Ravelli; Francesco Lanza; Francesco Scaglione
Journal:  Med Oncol       Date:  2015-07-30       Impact factor: 3.064

4.  Fc receptor-like 5 inhibits B cell activation via SHP-1 tyrosine phosphatase recruitment.

Authors:  Christopher L Haga; Götz R A Ehrhardt; Rebecca J Boohaker; Randall S Davis; Max D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-23       Impact factor: 11.205

5.  Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis.

Authors:  Yan Xing; Hideya Igarashi; Xiaodan Wang; Nobuo Sakaguchi
Journal:  J Exp Med       Date:  2005-08-29       Impact factor: 14.307

6.  Characterizing the structure-activity relationships of natural products, tanshinones, reveals their mode of action in inhibiting spleen tyrosine kinase.

Authors:  Min-Che Tung; Keng-Chang Tsai; Kit-Man Fung; Ming-Jaw Don; Tien-Sheng Tseng
Journal:  RSC Adv       Date:  2021-01-14       Impact factor: 3.361

7.  Anomalous constitutive Src kinase activity promotes B lymphoma survival and growth.

Authors:  Jiyuan Ke; R Lakshman Chelvarajan; Vishal Sindhava; Darrell A Robertson; Lazaros Lekakis; C Darrell Jennings; Subbarao Bondada
Journal:  Mol Cancer       Date:  2009-12-31       Impact factor: 27.401

8.  Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling.

Authors:  Y Banu; T Watanabe
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.